Lexagene-logo_srgb_1000px.jpg
LexaGene Announces Advancements to its Sample Preparation Cartridge for the Veterinary Market
March 29, 2022 07:45 ET | LexaGene Holdings Inc
BEVERLY, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System, a...
Lexagene-logo_srgb_1000px.jpg
LexaGene Finalizes Design of Pneumonia Panel
November 01, 2021 07:45 ET | LexaGene Holdings Inc
BEVERLY, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
Lexagene-logo_srgb_1000px.jpg
LexaGene Completes First Stage of U.S. ARMY DEVCOM Agreement
October 29, 2021 07:45 ET | LexaGene Holdings Inc
BEVERLY, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
Lexagene-logo_srgb_1000px.jpg
LexaGene’s MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation Summit
October 27, 2021 07:45 ET | LexaGene Holdings Inc
BEVERLY, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
Lexagene-logo_srgb_1000px.jpg
LexaGene Reports on Recent Veterinary Trade Shows
September 30, 2021 07:45 ET | LexaGene Holdings Inc
BEVERLY, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...
Lexagene-logo_srgb_1000px.jpg
LexaGene’s MiQLab™ Accurately Detects Multiple Strains of Pathogenic Bacteria in Polymicrobial Samples Compared to Conventional Culture
September 07, 2021 07:45 ET | LexaGene Holdings Inc
MiQLab detected both bacterial strains in polymicrobial samples in ~2 hoursCulture and Sensitivity Testing (C&ST) failed to detect the minor pathogen population in individual mixed samples, with...
Lexagene-logo_srgb_1000px.jpg
LexaGene’s MiQLab™ System Featured at Three Key Veterinary Tradeshows
September 03, 2021 07:45 ET | LexaGene Holdings Inc
September 7-9, WVC 93rd Annual Conference, Las Vegas, NVSeptember 12-14, International Veterinary Emergency and Critical Care, Nashville, TNSeptember 23-26, Southwest Veterinary Symposium, San...
Lexagene-logo_srgb_1000px.jpg
LexaGene Demonstrates a Simple and Inexpensive Multiplex PCR Chemistry with Shorter Lead Times for use on its MiQLab System
August 12, 2021 07:45 ET | LexaGene Holdings Inc
First point-of-need, PCR system capable of using conventional probe-based chemistry or inexpensive, rapidly available SYBR Green chemistry BEVERLY, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- LexaGene...
SAFE PRINT 360 - DEFENDER AGAINST BACTERIA
March 10, 2021 15:07 ET | Flottman Company
Cincinnati, Ohio - Northern Kentucky, March 10, 2021 (GLOBE NEWSWIRE) -- Introducing Safe Print 360, Flottman Company’s new antimicrobial substrate coating, formulated to inhibit 99% of bacterial...